Lukonis C J, Weller S K
Department of Microbiology, University of Connecticut Health Center, Farmington 06030, USA.
J Virol. 1996 Mar;70(3):1751-8. doi: 10.1128/JVI.70.3.1751-1758.1996.
Herpes simplex virus type 1 DNA replication occurs in nuclear domains termed replication compartments, which are areas of viral single-stranded DNA-binding protein (UL29) localization (M.P. Quinlan, L. B. Chen, and D. M. Knipe, Cell 36:857-868). In the presence of herpesvirus-specific polymerase inhibitors, UL29 localizes to punctate nuclear foci called prereplicative sites. Using versions of the helicase-primase complex proteins containing short peptide epitopes which can be detected in an immunofluorescence assay, we have found that the helicase-primase complex localizes to prereplicative sites and replication compartments. To determine if prereplicative site formation is dependent upon these and other essential viral replication proteins, we have studied UL29 localization in cells infected with replication-defective viruses. Cells infected with viruses that fail to express one of the three helicase-primase subunits or the origin-binding protein show a diffuse nuclear staining for UL29. However, in the presence of polymerase inhibitors, mutant-infected cells contain UL29 in prereplicative sites. Replication-defective viruses containing subtle mutations in the helicase or origin-binding proteins behaved identically to their null mutant counterparts. In contrast, cells infected with viral mutants which fail to express the polymerase protein contain prereplicative sites in the absence and presence of polymerase inhibitors. We propose that active viral polymerase prevents the formation of prereplicative sites. Models of the requirement of essential viral replication proteins in the assembly of prereplicative sites are presented.
1型单纯疱疹病毒DNA复制发生在称为复制区室的核区域,这些区域是病毒单链DNA结合蛋白(UL29)的定位区域(M.P. 昆兰、L.B. 陈和D.M. 克尼普,《细胞》36:857 - 868)。在存在疱疹病毒特异性聚合酶抑制剂的情况下,UL29定位于称为复制前位点的点状核灶。利用含有短肽表位的解旋酶 - 引发酶复合蛋白版本,这些表位可在免疫荧光测定中被检测到,我们发现解旋酶 - 引发酶复合物定位于复制前位点和复制区室。为了确定复制前位点的形成是否依赖于这些及其他必需的病毒复制蛋白,我们研究了在感染复制缺陷病毒的细胞中UL29的定位。感染了无法表达三种解旋酶 - 引发酶亚基之一或起始结合蛋白的病毒的细胞,对UL29呈现弥漫性核染色。然而,在存在聚合酶抑制剂的情况下,感染突变体的细胞在复制前位点含有UL29。在解旋酶或起始结合蛋白中含有细微突变的复制缺陷病毒,其行为与其无义突变对应物相同。相反,感染了无法表达聚合酶蛋白的病毒突变体的细胞,无论是否存在聚合酶抑制剂,都含有复制前位点。我们提出,活性病毒聚合酶可阻止复制前位点的形成。本文还提出了在复制前位点组装过程中必需病毒复制蛋白需求的模型。